Amphotericin B: The higher the dose, the higher the toxicity

Clinical Infectious Diseases

Volumn 47, Issue 8, 2008, Pages 1110-

  Pasqualotto, Alessandro C ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Hospital Dom Vicente Scherer   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; SODIUM CHLORIDE;

COMPARATIVE STUDY; DRUG CLEARANCE; DRUG DOSE COMPARISON; DRUG FATALITY; DRUG MEGADOSE; DRUG WITHDRAWAL; HEMATOLOGIC DISEASE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; LETTER; LOW DRUG DOSE; MENINGOENCEPHALITIS; PRIORITY JOURNAL; SIDE EFFECT;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUCONAZOLE; FLUCYTOSINE; HIV INFECTIONS; HUMANS; MENINGITIS, CRYPTOCOCCAL;

EID: 53349171967     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/592117     Document Type: Letter

References (1)

1. Bicanic T, Wood R, Meintjes G, et al. High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial. Clin Infect Dis 2008; 47:123-30.